Amarin Corporation

Amarin Corporation Liabilities

The The Liabilities of Amarin Corporation (AMRN) as of Nov 19, 2026 is 211.49 M USD. In the previous year, The Liabilities was 199.17 M USD — a change of 6.19% (higher).

Liabilities

211.49 MUSD

YoY

6.19%

Last updated:

In 2025, Amarin Corporation's total liabilities amounted to 211.49 M USD, a 6.19% difference from the 199.17 M USD total liabilities in the previous year.

The Amarin Corporation Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2018
233.38 M USD
Jan 1, 2019
273.95 M USD
Jan 1, 2020
338.52 M USD
Jan 1, 2021
400.97 M USD
Jan 1, 2022
290.85 M USD
Jan 1, 2023
279.59 M USD
Jan 1, 2024
199.17 M USD
Jan 1, 2025
211.49 M USD
The Amarin Corporation Liabilities history
YEARLiabilitiesYoY
211.49 MUSD+6.19%
199.17 MUSD-28.76%
279.59 MUSD-3.87%
290.85 MUSD-27.46%
400.97 MUSD+18.45%
338.52 MUSD+23.57%
273.95 MUSD+17.38%
233.38 MUSD+2.95%
226.70 MUSD+28.76%
176.06 MUSD-41.83%
302.65 MUSD+16.60%
259.56 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amarin Corporation Stock analysis

What does Amarin Corporation do? Amarin Corporation PLC generates revenue primarily through the sale of Vascepa (icosapent ethyl) capsules, approved by the FDA for reducing triglyceride levels in patients with severe hypertriglyceridemia. The company sells Vascepa to wholesalers, regional wholesalers, and specialty pharmacy providers, collectively referred to as distributors, who then resell the product to retail pharmacies for patient and healthcare provider use. The MARINE indication, derived from the MARINE study, is the key approved use driving sales in the cardiovascular health segment. Amarin's commercial strategy centers on the Vascepa segment, focusing on the development and commercialization of this therapeutic. The firm's lead product, Vascepa, is positioned as an adjunct to diet for treating severe hypertriglyceridemia, targeting healthcare providers and patients through a distribution network of wholesalers and specialty pharmacies. This model ensures Vascepa reaches retail pharmacies where it is dispensed to end users. Amarin Corporation is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Amarin Corporation's Liabilities

Amarin Corporation's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Amarin Corporation's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Amarin Corporation's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Amarin Corporation's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Amarin Corporation’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Amarin Corporation stock

The Liabilities of Amarin Corporation is 211.49 M USD in 2025.

The Liabilities of Amarin Corporation changed from 199.17 M USD to 211.49 M USD, representing a 6.19% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Amarin Corporation since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Amarin Corporation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Amarin Corporation

All Key Metrics — Amarin Corporation